Lmr Partners LLP Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $8.5 Million - $14.6 Million	59,300 Added 117.19%	109,900 $26.7 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $893,711 - $1.21 Million	-6,100 Reduced 10.76%	50,600 $7.56 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $6.01 Million - $7.45 Million	-35,200 Reduced 38.3%	56,700 $10 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $17 Million - $19.5 Million	91,900 New	91,900 $17.5 Million

648

110M

1.28M

1.22M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.